Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cannabis stocks are due for a boom soon. The U.S. government is still attempting to decriminalize pot, and cannabis stocks have been a disappointment for years, but we'll get there eventually.

Canopy Growth Is the Long-Term Pot Play You're Looking for

Trulieve Cannabis Corp.

Major Federal Cannabis Reform Could Be on the Way: Time to Load Up on Marijuana Stocks?

Innovative Industrial Properties

2 Ways To Invest In Pot Stocks During A Down Market The post How To Invest In Marijuana Stocks In A Down Market? 2 For Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

How To Invest In Marijuana Stocks In A Down Market? 2 For Your List Right Now

CGC stock peaked and slumped during 2021's first half, but there are reasons to believe that Canopy Growth is still a weed market leader. The post Aggressive Acquisitions and Revenue Improvement Favor Canopy Growth appeared first on InvestorPlace.

Aggressive Acquisitions and Revenue Improvement Favor Canopy Growth

Canopy Growth CEO David Klein reacts to the proposal to legalize recreational marijuana use on the federal level.

Democrats' marijuana legalization bill leaves Canopy Growth CEO optimistic

On Wednesday, Canopy Growth Corporation (NASDAQ:CGC) lost a key support level at $21.72 and on Thursday the stock continued to fall. There was investor excitement over Senate Majority Leader Chuck Schumer presenting draft legislation aimed at federally decriminalizing cannabis but bullish anticipation was overthrown by the bearish sentiment that plagues the cannabis sector during spring and early summer.

Options Traders Bet Canopy Growth Flies High In Months To Come

Aurora Cannabis

Cronos Group

OrganiGram Holdings Inc.

Tilray Brands

U.S. Senate Majority Leader Chuck Schumer, along with Senators Ron Wyden and Cory Booker, on Wednesday released a draft for comment of a proposed Cannabis Administration and Opportunity Act.

Analysts' Comments on Marijuana Stocks After Legalization Announcement

Top Canadian Marijuana You Should Know About In 2021 The post Do You Trade Canadian Marijuana Stocks? 2 You Should Know About In 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Do You Trade Canadian Marijuana Stocks? 2 You Should Know About In 2021

The debate on fully legalising marijuana in the United States sparked again on Wednesday as Senate Majority Leader Chuck Schumer proposed federal legislation to decriminalise weed. “This is monumental.

Cannabis stocks trade lower despite encouraging progress from Washington

HEXO Corp

Investors seem underwhelmed by the new marijuana legalization bill.

Why Hexo, Canopy Growth, and Aurora Cannabis Stocks All Just Crashed

The company has created some lofty expectations for itself, and investors will be counting on it to deliver.

Can Canopy Growth Get Back to $50 This Year?

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

The Cannabis Growth Portfolio is the premier research service in the cannabis sector. Nearly 40 states have already legalized medical cannabis, and I expect more dominoes to fall over the next 10 years.

Launching The Cannabis Growth Portfolio: The Generational Buying Opportunity In Cannabis

Cannabis stocks tend to hibernate during the summer and giants Canopy Growth Corporation (NASDAQ:CGC) and Tilray, Inc. (NASDAQ:TLRY) have lulled into a sleepy sideways action. The sideways action came after a months-long downtrend after Canopy Growth and Tilray climbed in unison and reached highs of $56.50 and $67, respectively, on Feb. 10.

Tilray, Canopy Growth Options Traders Place Their Bets

An analyst at investment bank Jefferies loves marijuana stocks -- just not these marijuana stocks.

Why Canopy Growth, Hexo, and Tilray Stocks All Tumbled Today

Image Provided By Photo Stock Editor With the global legal marijuana market projected to reach $70.6 billion by 2028, more and more entrepreneurs and investors are looking for opportunities to get a foothold in this emerging industry. The specific applications and consumer trends that will take off in the coming years remains to be seen, but one of the most future-proof ways to  enter the cannabis industry is to get in on the cultivation side.

Indoor, Outdoor or Greenhouse: What to Look for in Different Cannabis Growing Properties

SNDL Inc.

The grass simply isn't greener with this trio of poor-performing cannabis stocks.

3 Pot Stocks to Avoid Like the Plague in July

Anheuser-Busch InBev

Heineken NV

Altria

Constellation Brands

Molson Coors Brewing

Just because you can doesn't mean you should.

Maybe These Beverage Giants Should Have Stayed Away From Cannabis Drinks

Canadian Marijuana Stocks To Add To Your July Watchlist The post Best Canadian Marijuana Stocks To Buy? 2 To Watch In July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 2 To Watch In July

The Alternative Harvest exchange traded fund is up a healthy 38% year-to-date at $20.63. Over the past year, the ETF has risen 59%, outpacing broader stock markets.

3 Best Canadian Marijuana Stocks to Buy for the Upside Potential

CGC stock continues to lose money, with its rising operational expenses and massive debt burden The post Canopy Growth Will Continue Losing Money For the Foreseeable Future appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn't matter if you have $500 in savings or $5 million.

Canopy Growth Will Continue Losing Money For the Foreseeable Future

AFC Gamma

Arena Pharmaceuticals

Corbus Pharmaceuticals Holdings

Evogene

India Globalization Capital

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Pot Stocks in Focus: Cannabis-Based Pharmaceutical Trials

Nothing is certain, but the prospects are better than they've ever been.

Why Investors Can Be Cautiously Optimistic About Major Cannabis Reform in the U.S.

The Small Exchange celebrated its one-year anniversary with the launch of the first futures contract on marijuana stocks. Small Cannabis, listed under the S420 symbol, is based on an index that includes 21 producers and distributors of medical and recreational cannabis products.

S420: The First Ever U.S. Cannabis Equity Index Future Contract

Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) has merged with The Supreme Cannabis Company, Inc. (TSX:FIRE) (OTCQX:SPRWF), wrapping up their previously announced deal on Tuesday. Transaction Details: Canopy acquired all of the issued and outstanding common shares of Supreme, which became a wholly-owned subsidiary of Canopy.

Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co.

Cronos recently acquired an option to invest in a U.S.-based cannabis business.

This Canadian Cannabis Company Just Made a Big Move Toward U.S. Success

News for Canopy Growth Stock (CGC)